Rating Change
HC Wainwright & Co. analysts reiterated a Buy rating on uniQure N.V. (NASDAQ:QURE) on June 29, 2026.
reiterateNASDAQ:QURE
HC Wainwright & Co. Reiterates Buy Rating on uniQure N.V. (QURE)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on uniQure N.V. (NASDAQ:QURE) on June 29, 2026.
Market Context
uniQure N.V. operates in the Healthcare sector. The stock currently trades at $47.39 with a market capitalization of $1.1B.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for uniQure N.V..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for uniQure N.V.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 29, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 25, 2026 | Mizuho | Outperform | N/A |
| Jun 18, 2026 | Leerink Partners | Outperform | N/A |
| Jun 18, 2026 | Goldman Sachs | Neutral | N/A |
| Jun 18, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View QURE Stock Page
Frequently Asked Questions
What does a Buy rating mean for QURE?
A Buy rating from HC Wainwright & Co. reflects the analyst's outlook on uniQure N.V. (NASDAQ:QURE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the QURE forecast page.